SCHEMBL11962332

SCHEMBL11962332

c1ccc(-c2ccc3ccc4ccc(-c5ccc(Oc6cccc(-c7ccc8ccc9ccc(-c%10ccccc%10)nc9c8n7)c6)cc5)nc4c3n2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCL1 Q07820 3/20 0.47
▸ RAB9A P51151 2/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ GSTP1 P09211 1/20 0.45
▸ MAP4K4 O95819 1/20 0.44
▸ CYP11B1 P15538 1/20 0.44
▸ CYP11B2 P19099 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ XDH P47989 1/20 0.43
▸ PARP1 P09874 2/20 0.43
▸ MAOA P21397 1/20 0.43
▸ MAOB P27338 1/20 0.43
▸ SDHB P21912 1/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ GLA P06280 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17174120 0.95 MCL1 (0.48) MCL1RAB9ANPC1GSTP1CYP11B1
SCHEMBL17174130 0.95 MCL1 (0.48) MCL1RAB9ANPC1GSTP1CYP11B1
SCHEMBL17178156 0.94 MAP4K4 (0.46) MCL1RAB9AGSTP1MAP4K4CYP11B1
SCHEMBL17174117 0.91 MCL1 (0.47) MCL1RAB9ANPC1GSTP1CYP11B1
SCHEMBL17178155 0.91 P2RX3 (0.45) MCL1GSTP1MAP4K4CYP11B1CYP11B2
SCHEMBL11962279 0.90 RAB9A (0.50) MCL1RAB9ANPC1GSTP1CYP11B1
SCHEMBL17174119 0.89 NPC1 (0.47) MCL1RAB9ANPC1GSTP1CYP11B1
SCHEMBL11962342 0.88 NPC1 (0.42) MCL1RAB9ANPC1GSTP1MAP4K4
SCHEMBL11962307 0.88 ADORA1 (0.42) MCL1RAB9AMAP4K4PARP1MAOA
SCHEMBL11962305 0.87 MAP4K4 (0.46) MAP4K4CYP11B1CYP11B2TDP1PARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-9054319-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2015-06-09 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-8759819-B2 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2014-06-24 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20140131680-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2014-05-15 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-08-09 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed
US-20100283043-A1 ORGANIC EL ELEMENT IDEMITSU LOSAN CO., LTD. 2010-11-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120199817-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FTO, EML4, SLC43A1 MCL1 4552/4885RAB9A 559/4885NPC1 2352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback